Neurogene Inc. - Common Stock
Neurogene Inc. - Common Stock
Share · US64135M1053 · NGNE (XNAS)
Overview
Analyst Grade Summary
gauge-img
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
0
4
1
0
0
No Price
16.12.2025 00:30
Current Prices from Neurogene Inc. - Common Stock
ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
NGNE
USD
16.12.2025 00:30
20,25 USD
0,01 USD
+0,05 %
XDQU: Quotrix
Quotrix
NIRSN53.DUSD
EUR
15.12.2025 06:27
17,88 EUR
-
XDUS: Düsseldorf
Düsseldorf
NIRSN53.DUSB
EUR
11.12.2025 18:30
17,69 EUR
-
Share Float & Liquidity
Free Float 79,78 %
Shares Float 12,36 M
Shares Outstanding 15,49 M
Company Profile for Neurogene Inc. - Common Stock Share
Neurogene Inc. develops life-changing genetic medicines for patients and their families affected by neurological diseases. Its product candidate includes NGN-401, an investigational AAV9 gene therapy for the treatment of Rett syndrome; and NGN-101 to treat neuronal ceroid lipofuscinosis subtype 5 batten disease. The company is headquartered in New York, New York.
Get up to date insights from finAgent about Neurogene Inc. - Common Stock

Company Data

Name Neurogene Inc. - Common Stock
Company Neurogene Inc.
Symbol NGNE
Website https://www.neurogene.com
Primary Exchange XNAS NASDAQ
ISIN US64135M1053
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Rachel L. McMinn
Market Capitalization 314 Mio
Country United States of America
Currency USD
Employees 0,1 T
Address 535 W 24th Street, 10011 New York City
IPO Date 2014-03-07

ID Changes

Date From To
19.12.2023 NLTX NGNE
12.08.2019 AQXP NLTX

Ticker Symbols

Name Symbol
Düsseldorf NIRSN53.DUSB
Frankfurt UU8.F
NASDAQ NGNE
Quotrix NIRSN53.DUSD
More Shares
Investors who hold Neurogene Inc. - Common Stock also have the following shares in their portfolio:
Axonic Alternative Income Fund
Axonic Alternative Income Fund Fund
DIOK GREEN      ANL.24/29
DIOK GREEN ANL.24/29 Bond
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025